
Dentsply Sirona (XRAY) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
879.0M
Gross Profit
466.0M
53.01%
Operating Income
70.0M
7.96%
Net Income
19.0M
2.16%
EPS (Diluted)
$0.10
Balance Sheet Metrics
Total Assets
6.0B
Total Liabilities
4.0B
Shareholders Equity
2.0B
Debt to Equity
2.01
Cash Flow Metrics
Operating Cash Flow
52.0M
Free Cash Flow
-12.0M
Revenue & Profitability Trend
Dentsply Sirona Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 3.8B | 4.0B | 3.9B | 4.2B | 3.3B |
Cost of Goods Sold | 1.8B | 1.9B | 1.8B | 1.9B | 1.7B |
Gross Profit | 2.0B | 2.1B | 2.1B | 2.3B | 1.7B |
Gross Margin % | 51.6% | 52.6% | 54.2% | 55.5% | 49.6% |
Operating Expenses | |||||
Research & Development | 165.0M | 184.0M | 174.0M | 171.0M | 123.0M |
Selling, General & Administrative | 1.6B | 1.6B | 1.6B | 1.6B | 1.3B |
Other Operating Expenses | - | - | - | - | - |
Total Operating Expenses | 1.8B | 1.8B | 1.8B | 1.7B | 1.4B |
Operating Income | 188.0M | 282.0M | 357.0M | 625.0M | 231.0M |
Operating Margin % | 5.0% | 7.1% | 9.1% | 14.8% | 6.9% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | 1.0M |
Interest Expense | 69.0M | 81.0M | 65.0M | 61.0M | 46.0M |
Other Non-Operating Income | -1.1B | -376.0M | -1.3B | -19.0M | -235.0M |
Pre-tax Income | -936.0M | -175.0M | -1.1B | 545.0M | -50.0M |
Income Tax | -26.0M | -43.0M | -105.0M | 134.0M | 23.0M |
Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 24.6% | 0.0% |
Net Income | -910.0M | -132.0M | -950.0M | 411.0M | -73.0M |
Net Margin % | -24.0% | -3.3% | -24.2% | 9.7% | -2.2% |
Key Metrics | |||||
EBITDA | 528.0M | 620.0M | 648.0M | 969.0M | 551.0M |
EPS (Basic) | $-4.48 | $-0.62 | $-4.41 | $1.93 | $-0.38 |
EPS (Diluted) | $-4.48 | $-0.62 | $-4.41 | $1.91 | $-0.38 |
Basic Shares Outstanding | 203200000 | 212000000 | 215500000 | 218400000 | 219200000 |
Diluted Shares Outstanding | 203200000 | 212000000 | 215500000 | 218400000 | 219200000 |
Income Statement Trend
Dentsply Sirona Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 272.0M | 334.0M | 365.0M | 339.0M | 438.0M |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 556.0M | 695.0M | 632.0M | 750.0M | 667.0M |
Inventory | 564.0M | 624.0M | 627.0M | 515.0M | 476.0M |
Other Current Assets | 153.0M | 113.0M | 88.0M | 84.0M | 67.0M |
Total Current Assets | 1.7B | 2.0B | 1.9B | 1.9B | 1.8B |
Non-Current Assets | |||||
Property, Plant & Equipment | 136.0M | 178.0M | 200.0M | 198.0M | 176.0M |
Goodwill | 4.4B | 6.6B | 7.3B | 10.3B | 10.5B |
Intangible Assets | 1.2B | 1.7B | 1.9B | 2.3B | 2.5B |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 301.0M | 276.0M | 198.0M | 121.0M | 95.0M |
Total Non-Current Assets | 4.0B | 5.4B | 5.8B | 7.4B | 7.6B |
Total Assets | 5.8B | 7.4B | 7.6B | 9.2B | 9.4B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 241.0M | 305.0M | 279.0M | 262.0M | 302.0M |
Short-term Debt | 595.0M | 378.0M | 172.0M | 232.0M | 347.0M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 12.0M | 18.0M | 19.0M | 3.0M | 32.0M |
Total Current Liabilities | 1.6B | 1.4B | 1.2B | 1.3B | 1.4B |
Non-Current Liabilities | |||||
Long-term Debt | 1.7B | 1.9B | 2.0B | 2.1B | 2.1B |
Deferred Tax Liabilities | 129.0M | 228.0M | 287.0M | 391.0M | 381.0M |
Other Non-Current Liabilities | 415.0M | 502.0M | 399.0M | 528.0M | 554.0M |
Total Non-Current Liabilities | 2.2B | 2.7B | 2.7B | 3.0B | 3.0B |
Total Liabilities | 3.8B | 4.1B | 3.8B | 4.2B | 4.4B |
Equity | |||||
Common Stock | 3.0M | 3.0M | 3.0M | 3.0M | 3.0M |
Retained Earnings | -835.0M | 205.0M | 456.0M | 1.5B | 1.2B |
Treasury Stock | 3.1B | 2.9B | 2.6B | 2.5B | 2.4B |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 1.9B | 3.3B | 3.8B | 5.0B | 4.9B |
Key Metrics | |||||
Total Debt | 2.3B | 2.3B | 2.1B | 2.3B | 2.5B |
Working Capital | 157.0M | 548.0M | 723.0M | 591.0M | 426.0M |
Balance Sheet Composition
Dentsply Sirona Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | -910.0M | -132.0M | -950.0M | 411.0M | -73.0M |
Depreciation & Amortization | 349.0M | 343.0M | 328.0M | 346.0M | 334.0M |
Stock-Based Compensation | 39.0M | 46.0M | 59.0M | 48.0M | 47.0M |
Working Capital Changes | 96.0M | -15.0M | -39.0M | -211.0M | 171.0M |
Operating Cash Flow | -571.0M | 140.0M | -780.0M | 576.0M | 420.0M |
Investing Activities | |||||
Capital Expenditures | - | 7.0M | 0 | 0 | 1.0M |
Acquisitions | 0 | 13.0M | 0 | -220.0M | -1.1B |
Investment Purchases | -12.0M | - | - | - | -1.0M |
Investment Sales | 1.0M | 39.0M | 13.0M | 2.0M | 58.0M |
Investing Cash Flow | -17.0M | 60.0M | 11.0M | -216.0M | -1.0B |
Financing Activities | |||||
Share Repurchases | -250.0M | -300.0M | -150.0M | -200.0M | -228.0M |
Dividends Paid | -126.0M | -116.0M | -104.0M | -92.0M | -88.0M |
Debt Issuance | 1.0M | 0 | 6.0M | 16.0M | 1.4B |
Debt Repayment | -88.0M | -7.0M | -2.0M | -297.0M | -701.0M |
Financing Cash Flow | -302.0M | -307.0M | -335.0M | -430.0M | 377.0M |
Free Cash Flow | 281.0M | 228.0M | 368.0M | 515.0M | 562.0M |
Net Change in Cash | -890.0M | -107.0M | -1.1B | -70.0M | -222.0M |
Cash Flow Trend
Dentsply Sirona Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-3.27
Forward P/E
7.33
Price to Book
1.49
Price to Sales
0.80
PEG Ratio
0.00
Profitability Ratios
Profit Margin
-25.85%
Operating Margin
11.65%
Return on Equity
-37.73%
Return on Assets
2.72%
Financial Health
Current Ratio
1.69
Debt to Equity
127.95
Beta
0.96
Per Share Data
EPS (TTM)
$-4.68
Book Value per Share
$9.83
Revenue per Share
$18.40
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
xray | 2.9B | -3.27 | 1.49 | -37.73% | -25.85% | 127.95 |
Intuitive Surgical | 170.7B | 66.23 | 9.56 | 16.04% | 28.51% | 0.00 |
Becton, Dickinson | 57.2B | 36.50 | 2.25 | 6.18% | 7.41% | 75.93 |
AptarGroup | 9.3B | 24.47 | 3.45 | 15.26% | 10.84% | 43.12 |
Avantor | 9.0B | 13.14 | 1.44 | 11.73% | 10.31% | 67.49 |
Repligen | 7.0B | 511.11 | 3.40 | -0.68% | -2.05% | 33.28 |
Financial data is updated regularly. All figures are in the company's reporting currency.